Financial Synergies Wealth Advisors, Inc. Gilead Sciences, Inc. Transaction History

Financial Synergies Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$71.58 - $87.29 $10,880 - $13,268	152 New	152 $11.1 Million
Q4 2023 Apr 04, 2024	SELL	$73.27 - $83.09 $20,955 - $23,763	-286 Closed	0 $0
Q3 2023 Apr 04, 2024	BUY	$73.94 - $80.67 $73 - $80	1 Added 0.35%	286 $21.5 Million
Q2 2023 Apr 04, 2024	BUY	$76.01 - $86.7 $152 - $173	2 Added 0.71%	285 $21.9 Million
Q1 2023 Apr 04, 2024	BUY	$77.31 - $88.08 $21,878 - $24,926	283 New	283 $23.5 Million

1,886

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $96.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.